Tumor necrosis factor activities and cancer therapy — A perspective
- 31 December 1993
- journal article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 57 (1) , 79-128
- https://doi.org/10.1016/0163-7258(93)90037-e
Abstract
No abstract availableKeywords
This publication has 403 references indexed in Scilit:
- Nitric oxide mediates tumor necrosis factor-α cytotoxicity in endothelial cellsBiochemical and Biophysical Research Communications, 1992
- A phase I study of local treatment of liver metastases with recombinant tumour necrosis factorEuropean Journal Of Cancer, 1992
- Induction of Mn-superoxide dismutase by Tumor Necrosis Factor, Interleukin-1 and Interleukin-6 in human hepatoma cellsBiochemical and Biophysical Research Communications, 1992
- Danazol Suppresses the Production of Interleukin‐1β and Tumor Necrosis Factor by Human MonocytesAmerican Journal of Reproductive Immunology, 1990
- Tumor necrosis factor-α induces the phosphorylation of 28kDa stress proteins in endothelial cells: Possible role in protection against cytotoxicity?Biochemical and Biophysical Research Communications, 1989
- Cyclosporine a inhibits TNF production without decreasing TNF mRNA levelsBiochemical and Biophysical Research Communications, 1989
- Tumor necrosis factor enhances replication of human immunodeficiency virus (HIV) in vitroBiochemical and Biophysical Research Communications, 1989
- Tumor Necrosis Factor and Interleuktn-1 in the Serum of Children with Severe Infectious PurpuraNew England Journal of Medicine, 1988
- Reduced tumour necrosis factor-induced cytotoxicity by inhibitors of the arachidonic acid metabolismBiochemical and Biophysical Research Communications, 1987
- Cytotoxicity of tumor necrosis factor for thyroid epithelial cells and its regulation by interferon‐γEuropean Journal of Immunology, 1987